Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population

BACKGROUND: The FibroScan® XL probe reduces failure of liver stiffness measurement (LSM) and unreliable results in obese patients. OBJECTIVE: The objective of this article is to evaluate the accuracy of controlled attenuation parameter (CAP) obtained using the XL probe for the estimation of hepatic...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:United European Gastroenterol J
Auteurs principaux: Chan, Wah-Kheong, Nik Mustapha, Nik Raihan, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun, Mahadeva, Sanjiv
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2016
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5384552/
https://ncbi.nlm.nih.gov/pubmed/28405325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640616646528
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires